Advanced breath analysis through hierarchical deep convolutional neural network for multi-cancer screening - Top-Institutions - MDSpire

Advanced breath analysis through hierarchical deep convolutional neural network for multi-cancer screening

  • By

  • Byeongju Lee

  • Junyeong Lee

  • Hyowoong Noh

  • Hyung-Keun Bahn

  • Jae-Hyun Jeon

  • Inkyu Park

  • Sanghoon Jheon

  • Dae-Sik Lee

  • January 8, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Oncology
    • Biomedical Engineering
    • Artificial Intelligence in Medicine

  • #2

    Stanford University School of Medicine
    Stanford University School of Medicine

    Stanford, CA

    Key Differentiators

    • Oncology
    • Biomedical Informatics
    • Artificial Intelligence

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Oncology
    • Biomedical Engineering
    • Clinical Research

  • #4

    University of California, San Diego (UCSD)
    University of California, San Diego (UCSD)

    San Diego, CA

    Key Differentiators

    • Biomedical Engineering
    • Oncology
    • Artificial Intelligence

  • #5

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology
    • Cancer Diagnostics
    • Translational Research

Original Source(s)

Advanced breath analysis through hierarchical deep convolutional neural network for multi-cancer screening

  • by Byeongju Lee, Junyeong Lee, Hyowoong Noh, Hyung-Keun Bahn, Jae-Hyun Jeon, Inkyu Park, Sanghoon Jheon, Dae-Sik Lee

  • January 8, 2026

Related Content

Imaging features of lung cancer with cystic airspaces: clinical utility, challenges, and perspectives

Risk prediction models for postoperative atrial fibrillation in patients with lung cancer: a systematic review and meta-analysis

Editorial: Discovery of small molecule lead compounds: a driving force to unravel new anti-cancer targets and mechanisms, volume III